Rdl Pharmaceutical Laboratory Inc · 66-41 · PHILIPPINES

For Rdl Pharmaceutical Laboratory Inc · 66-41 · PHILIPPINES, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is PHILIPPINES; product is Hydroquinone Tretinoin Babyface Solution Anti-Acne Keratolytic Depigmenting Agent | Hydroquinone Tretinoin Babyface Solution Anti-Acne Keratolytic Depigmenting Agent | Hydroquinone Tretinoin Babyface Solution Anti-Acne Keratolytic Depigmenting Agent; product code is 63 V - - 02 Hydroquinone (Depigmentor) | 64 X - - 07 Tretinoin (Keratolytic) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 01/19/2018; address is Catitipan Diversion Road, Buhangin , Davao City, PHILIPPINES, verified against its source on 2026-09-16.

What the source says

Rdl Pharmaceutical Laboratory Inc Date Published : 01/19/2018 Catitipan Diversion Road, Buhangin , Davao City, PHILIPPINES 63 V - - 02 Hydroquinone (Depigmentor) Date Published: 01/19/2018 Desc: Hydroquinone Tretinoin Babyface Solution Anti-Acne Keratolytic Depigmenting Agent 64 X - - 07 Tretinoin (Keratolytic) Date Published: 01/19/2018 Desc: Hydroquinone Tretinoin Babyface Solution Anti-Acne Keratolytic Depigmenting Agent 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 01/19/2018 Desc: Hydroquinone Tretinoin Babyface Solution Anti-Acne Keratolytic Depigmenting Agent

— accessdata.fda.gov, retrieved 2026-09-15

Source

• accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified against source: 2026-09-16. Due for re-check by 2026-11-15. This page as Markdown · OKF bundle · full dataset as JSON.